Zomedica Pharmaceuticals Corp Stock Overlap Studies Triangular Moving Average

ZOM Stock  USD 0.12  0  2.50%   
Zomedica Pharmaceuticals overlap studies tool provides the execution environment for running the Triangular Moving Average study and other technical functions against Zomedica Pharmaceuticals. Zomedica Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triangular Moving Average study function is designed to identify and follow existing trends. Zomedica Pharmaceuticals overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Triangular Moving Average shows Zomedica Pharmaceuticals double smoothed mean price over a specified number of previous prices (i.e., averaged twice).

Zomedica Pharmaceuticals Technical Analysis Modules

Most technical analysis of Zomedica Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zomedica from various momentum indicators to cycle indicators. When you analyze Zomedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Zomedica Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zomedica Pharmaceuticals Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zomedica Pharmaceuticals Corp based on widely used predictive technical indicators. In general, we focus on analyzing Zomedica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zomedica Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Zomedica Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Zomedica Pharmaceuticals, we also check how macroeconomic factors affect Zomedica Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Days Sales Outstanding35.9431.8549.64
PTB Ratio0.60.820.78
Hype
Prediction
LowEstimatedHigh
0.010.124.14
Details
Intrinsic
Valuation
LowRealHigh
0.081.595.61
Details
1 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Align your values with your investing style

In addition to having Zomedica Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zomedica Pharmaceuticals is a strong investment it is important to analyze Zomedica Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zomedica Pharmaceuticals' future performance. For an informed investment choice regarding Zomedica Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.06)
Revenue Per Share
0.027
Quarterly Revenue Growth
0.018
Return On Assets
(0.09)
Return On Equity
(0.24)
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.